NORCET 5 Prelims - Sept 2023 (Shift-1)
Child Health Nursing (Pediatrics)
Hard

Which vaccine should not be given to an HIV positive newborn?

Appeared in: NORCET 5 Prelims - Sept 2023 (Shift-1)

Explanation

  • BCG is a live attenuated bacterial vaccine.
  • In individuals with compromised cellular immunity, such as HIV-positive newborns, the live bacteria in the BCG vaccine can cause a severe and often fatal disseminated infection (BCG-osis).
  • The World Health Organization (WHO) specifically recommends against giving BCG vaccine to children who are known to be HIV-infected.
  • This contraindication is absolute for newborns at birth, as their HIV status may be confirmed or suspected, and their immune system is immature.

Why Other Options Were Wrong

  • Option B: Measles vaccine (as part of MMR) is a live vaccine, but it is not given at birth. It is typically administered at 9-12 months. It is recommended for HIV-positive children who are not severely immunosuppressed because the risk from natural measles is very high.
  • Option C: Rubella vaccine (as part of MMR) is a live vaccine, but it is not administered at birth. It is given at 9-12 months and is generally considered safe for HIV-positive children who are not severely immunocompromised.
  • Option D: Mumps vaccine (as part of MMR) is a live vaccine not given at birth. Its administration follows the same guidelines as measles and rubella for HIV-positive children—given at 9-12 months and contraindicated only in severe immunosuppression.

Related Visual

A comparative chart showing the immunization schedule for a healthy infant versus an HIV-exposed infant. The chart should clearly mark BCG as Contraindicated at birth for the...
Clinical Relevance
  • Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Vaccine contraindications in immunocompromised infants as background academic context rather than a clinical decision trigger.
  • A nurse's primary responsibility before administering any vaccine, especially at birth, is to review the maternal and infant history for any contraindications, including maternal HIV status.
  • For infants born to HIV-positive mothers, BCG vaccination should be deferred until the infant's HIV status is confirmed to be negative. This is a critical patient safety measure.
  • Nurses play a key role in educating parents about the modified vaccination schedule for HIV-exposed infants and the reasons for these precautions.
How to Approach the Question
  • First, identify the key clinical information in the question: the patient is an 'HIV positive newborn'. This points to an immunocompromised state from birth.
  • Next, understand the question's core task, which is to identify a vaccine that should 'not be given' (a contraindication).
  • Recall the general principle of vaccination: live attenuated vaccines are generally contraindicated in severely immunocompromised individuals.
  • Evaluate all the options provided (BCG, Measles, Mumps, Rubella). Recognize that all are live vaccines.
  • Differentiate between the options based on the specific context of a 'newborn'. BCG is unique as it is typically administered at birth. The others (as MMR) are given later.
  • Synthesize the information: The risk of a live vaccine is highest when the immune system is weakest. For a newborn with HIV, the immediate risk comes from the vaccine given at birth. Therefore, BCG is the most definitive contraindication among the choices.
Concept Tested & Keywords
  • Concept Tested: Vaccine contraindications in immunocompromised infants.
  • Stem keywords: vaccine, HIV positive, newborn
  • Lead-in keywords: not be given
  • Clinical cues: Patient is a newborn, which is a critical factor for the timing of vaccinations.
  • Clinical cues: Patient is HIV positive, indicating an immunocompromised state.

Question ID

Qfnrc8y3_x1n4UOylNEnRb

Reference Book

E6 Parks TextBook of Preventive & Social Medicine part 1 — Subpart B (pp 202-403 of 604) p. 43-45

E6 Nelson Textbook of Pediatrics(2024) — Volume 1 p. 1613-1615

Practise the full NORCET 5 Prelims - Sept 2023 (Shift-1)

Attempt every question from this paper in a timed mock, then review the full solution for each one.

More Immunization and Immunodeficiency Questions

More NORCET 5 Prelims - Sept 2023 (Shift-1) Questions